Psychiatry and Neurology, Neurology · Bayamon, PR
NPI
1245455336
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
505 Instituo San Pablo, 505
Bayamon, PR, 00961
Phone (787) 786-4511
Medicare paid, 2024
$22K
194 services
Medicare patients, 2024
66
Average age 79
Drug cost, 2024
$1.0M
5,585 prescriptions
Company payments, 2025
$458
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rene Sanchez-Borrero was code 99214 (office e&m - established), 92 times for 51 patients. In total Rene Sanchez-Borrero billed 194 services in 12 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 92 | 51 | $86.62 | $7,969 |
| 99213 Office E&M - Established | Office | 24 | 20 | $69.50 | $1,668 |
| 95819 Neurologic | Office | 19 | 19 | $328.42 | $6,240 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 13 | 13 | $108.23 | $1,407 |
| 93886 Ultrasound - Nonspecific | Office | 13 | 13 | $212.54 | $2,763 |
| 99204 Office E&M - New | Office | 11 | 11 | $129.14 | $1,421 |
By year: 2022 $26K for 201 services; 2023 $26K for 213 services; 2024 $22K for 194 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rene Sanchez-Borrero prescribed most often to Medicare patients was Rivastigmine, with 695 prescriptions and refills. In total Rene Sanchez-Borrero wrote 5,585 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rivastigmine Generic | 695 | 845 | 142 | $88K |
| Rytary Carbidopa/Levodopa | 500 | 516 | 41 | $202K |
| Memantine Hcl Generic | 463 | 514 | 90 | $8,226 |
| Memantine Hcl Er Memantine Hcl | 343 | 415 | 72 | $27K |
| Donepezil Hcl Generic | 338 | 435 | 83 | $2,863 |
| Rivastigmine Rivastigmine Tartrate | 315 | 376 | 61 | $15K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 245 | 290 | 45 | $6,524 |
| Sertraline Hcl Generic | 188 | 216 | 36 | $1,500 |
| Omeprazole Generic | 184 | 232 | 51 | $1,738 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 172 | 193 | 25 | $1,898 |
| Levetiracetam Generic | 163 | 198 | 27 | $3,420 |
| Clopidogrel Clopidogrel Bisulfate | 155 | 194 | 46 | $862 |
| Olanzapine Generic | 127 | 146 | 30 | $1,284 |
| Gabapentin Generic | 126 | 155 | 36 | $1,233 |
| Clonazepam Generic | 88 | 88 | 26 | $905 |
Brand drugs: 1,015 claims; generic drugs: 4,570 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rene Sanchez-Borrero $458 ($458 in general payments such as food, travel and fees) from 4 companies. The largest payer was Harmony Biosciences LLC with $311.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.